{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:17:11Z","timestamp":1778620631853,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015620","name":"Institute for Bioengineering and Biosciences","doi-asserted-by":"publisher","award":["UID\/BIO\/04565\/2020"],"award-info":[{"award-number":["UID\/BIO\/04565\/2020"]}],"id":[{"id":"10.13039\/501100015620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015620","name":"Institute for Bioengineering and Biosciences","doi-asserted-by":"publisher","award":["007317"],"award-info":[{"award-number":["007317"]}],"id":[{"id":"10.13039\/501100015620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SFRH\/BD\/121417\/2016"],"award-info":[{"award-number":["SFRH\/BD\/121417\/2016"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","award":["VKR18333"],"award-info":[{"award-number":["VKR18333"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04469\/2020"],"award-info":[{"award-number":["UIDB\/04469\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-028893"],"award-info":[{"award-number":["POCI-01-0145-FEDER-028893"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000004"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000004"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/121417\/2016"],"award-info":[{"award-number":["SFRH\/BD\/121417\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.nano.2021.102469","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T06:44:30Z","timestamp":1633157070000},"page":"102469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Antisense locked nucleic acid gapmers to control Candida albicans filamentation"],"prefix":"10.1016","volume":"39","author":[{"given":"Daniela","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalila","family":"Mil-Homens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elisa","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Trolle","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Wengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f3nia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.nano.2021.102469_bb0005","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nano.2021.102469_bb0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.2006.04403.x","article-title":"Antisense oligonucleotides: from design to therapeutic application","volume":"33","author":"Chan","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"10.1016\/j.nano.2021.102469_bb0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1432-1033.2003.03555.x","article-title":"Antisense technologies: improvement through novel chemical modifications","volume":"270","author":"Kurreck","year":"2003","journal-title":"Eur J Biochem"},{"issue":"3","key":"10.1016\/j.nano.2021.102469_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"14","key":"10.1016\/j.nano.2021.102469_bb0025","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/S0040-4020(98)00094-5","article-title":"LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition","volume":"54","author":"Koshkin","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.nano.2021.102469_bb0030","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1016\/S0040-4039(98)01084-3","article-title":"Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2\u2019-O,4\u2019-C-methyleneribonucleosides","volume":"39","author":"Obika","year":"1998","journal-title":"Tetrahedron Lett"},{"issue":"1","key":"10.1016\/j.nano.2021.102469_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1039\/C0OB00532K","article-title":"Amino acids attached to 2\u2032-amino-LNA: synthesis and excellent duplex stability","volume":"9","author":"Johannsen","year":"2011","journal-title":"Org Biomol Chem"},{"issue":"22","key":"10.1016\/j.nano.2021.102469_bb0040","doi-asserted-by":"crossref","first-page":"10845","DOI":"10.1021\/acs.joc.6b01917","article-title":"Synthesis and biophysical investigations of oligonucleotides containing galactose-modified DNA, LNA, and 2\u2032-amino-LNA monomers","volume":"81","author":"Ries","year":"2016","journal-title":"J Org Chem"},{"issue":"6","key":"10.1016\/j.nano.2021.102469_bb0045","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/cbic.200400419","article-title":"On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide","volume":"6","author":"Fluiter","year":"2005","journal-title":"Chembiochem"},{"issue":"10","key":"10.1016\/j.nano.2021.102469_bb0050","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.nano.2021.102469_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-014-2230-8","article-title":"Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole","volume":"34","author":"Heimann","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.nano.2021.102469_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.nano.2021.102469_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jof3010008","article-title":"Candida species biofilms\u2019 antifungal resistance","volume":"3","author":"Silva","year":"2017","journal-title":"J Fungi"},{"issue":"2","key":"10.1016\/j.nano.2021.102469_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.nano.2021.102469_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tim.2016.09.004","article-title":"Portrait of Candida species biofilm regulatory network genes","volume":"1","author":"Ara\u00fajo","year":"2017","journal-title":"Trends Microbiol"},{"issue":"8","key":"10.1016\/j.nano.2021.102469_bb0080","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/emboj\/16.8.1982","article-title":"Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi","volume":"16","author":"Stoldt","year":"1997","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.nano.2021.102469_bb0085","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.cub.2005.05.047","article-title":"Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p","volume":"15","author":"Nobile","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.nano.2021.102469_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","article-title":"A recently evolved transcriptional network controls biofilm development in Candida albicans","volume":"148","author":"Nobile","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nano.2021.102469_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/mmi.12345","article-title":"The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis","volume":"90","author":"Connolly","year":"2013","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.nano.2021.102469_bb0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2019.09.016","article-title":"Application of 2\u2032-OMethylRNA\u2032 antisense oligomer to control Candida albicans EFG1 virulence determinant","volume":"18","author":"Ara\u00fajo","year":"2019","journal-title":"Mol Ther - Nucleic Acids"},{"key":"10.1016\/j.nano.2021.102469_bb0105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/IDR.S202058","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China","author":"Yao","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"10","key":"10.1016\/j.nano.2021.102469_bb0110","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1099\/13500872-142-10-2731","article-title":"Specific detection of Candida albicans and Candida tropicalis by fluorescent in situ hybridization with an 18S rRNA-targeted oligonucleotide probe","volume":"142","author":"Lischewski","year":"1996","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.nano.2021.102469_bb0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/nat.2013.0436","article-title":"Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern","volume":"23","author":"Hagedorn","year":"2013","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.nano.2021.102469_bb0120","unstructured":"Navarro IB, Nava A. Oligonucleotides of Candida albicans, detection method and kit comprising same. WO 2015\/060704A1."},{"key":"10.1016\/j.nano.2021.102469_bb0125","unstructured":"Testa S, Disney M, Gryaznov S, Turner D. Methods and compositions for inhibition of rna splicing. WO2000055374."},{"key":"10.1016\/j.nano.2021.102469_bb0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s13311-013-0194-5","article-title":"Antisense oligonucleotides\u202f: treating neurodegeneration at the level of RNA","volume":"10","author":"DeVos","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nano.2021.102469_bb0135","series-title":"ISO10993-5:2009. Biological evaluation of medical devices. Part 5: tests for in vitro cytotoxicity","author":"International Organization for Standardization","year":"2009"},{"issue":"9","key":"10.1016\/j.nano.2021.102469_bb0140","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1128\/jcm.33.9.2476-2479.1995","article-title":"Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA","volume":"33","author":"Williams","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nano.2021.102469_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-7-25","article-title":"Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR","volume":"7","author":"Nailis","year":"2006","journal-title":"BMC Mol Biol"},{"issue":"1","key":"10.1016\/j.nano.2021.102469_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1574-6968.2011.02476.x","article-title":"The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia","volume":"328","author":"Mil-Homens","year":"2012","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"10.1016\/j.nano.2021.102469_bb0155","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/jam.13145","article-title":"Fish oils against Burkholderia and Pseudomonas aeruginosa: in vitro efficacy and their therapeutic and prophylactic effects on infected galleria mellonella larvae","volume":"120","author":"Mil-Homens","year":"2016","journal-title":"J Appl Microbiol"},{"issue":"3","key":"10.1016\/j.nano.2021.102469_bb0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ajcp\/68.3.427","article-title":"Rapid Grocott\u2019s methenamine silver nitrate method for fungi and pneumocystis carinii","volume":"68","author":"Churukian","year":"1977","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.nano.2021.102469_bb0165","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4081\/ejh.2014.2428","article-title":"A histological procedure to study fungal infection in the wax moth Galleria mellonella","volume":"58","author":"Perdoni","year":"2014","journal-title":"Eur J Histochem"},{"issue":"3","key":"10.1016\/j.nano.2021.102469_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/bip.22579","article-title":"Biophysical properties and thermal stability of oligonucleotides of RNA containing 7,8-dihydro-8-hydroxyadenosine","volume":"103","author":"Chauca-Diaz","year":"2015","journal-title":"Biopolymers"},{"issue":"2","key":"10.1016\/j.nano.2021.102469_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149478","article-title":"Thermodynamic features of structural motifs formed by \u03b2-L-RNA","volume":"11","author":"Szabat","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2021.102469_bb0180","series-title":"Biomacromolecules structure: nucleic acids. Biomacromolecules: introduction to structure, function and informatics","first-page":"55","author":"Tsai","year":"2007"},{"issue":"4","key":"10.1016\/j.nano.2021.102469_bb0185","first-page":"2099","article-title":"Biophysical properties, thermal stability and functional impact of 8-oxo-7,8-dihydroguanine on oligonucleotides of RNA\u2013\u2013a study of duplex, hairpins and the aptamer for preQ1 as models","volume":"45","author":"Choi","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.nano.2021.102469_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4161\/viru.22493","article-title":"Galleria mellonella as a model host for human pathogens","volume":"3","author":"Junqueira","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.nano.2021.102469_bb0195","series-title":"Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology. Vol. 14, oligonucleotides","first-page":"130","author":"Jepsen","year":"2004"},{"issue":"11","key":"10.1016\/j.nano.2021.102469_bb0200","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2174\/138161208784246234","article-title":"Locked nucleic acid holds promise in the treatment of cancer","volume":"14","author":"Frieden","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1016\/j.nano.2021.102469_bb0205","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1158\/1078-0432.CCR-08-3257","article-title":"Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development","volume":"15","author":"Yamamichi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.nano.2021.102469_bb0210","first-page":"1083","article-title":"Locked nucleic acid in situ hybridization analysis of microRNA-21 predicts clinical outcome in patients after resection for pancreatic cancer treated with adjuvant gemcitabine monotherapy","volume":"36","author":"Morinaga","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"45","key":"10.1016\/j.nano.2021.102469_bb0215","doi-asserted-by":"crossref","first-page":"73651","DOI":"10.18632\/oncotarget.12043","article-title":"Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo","volume":"7","author":"Torres","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.nano.2021.102469_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cgt.2016.10","article-title":"Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation","volume":"23","author":"Ahmadi","year":"2016","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"10.1016\/j.nano.2021.102469_bb0225","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/cgt.2016.25","article-title":"Locked nucleic acid anti-MIR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-MIR as a novel approach","volume":"23","author":"Nedaeinia","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.nano.2021.102469_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.acc.2017.10.002","article-title":"Locked nucleic acid technology for highly sensitive detection of somatic mutations in cancer","volume":"83","author":"Ishige","year":"2018","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.nano.2021.102469_bb0235","first-page":"900","article-title":"Inhibition of hepatitis B virus (HBV) replication using antisense LNA targeting to both S and C genes in HBV","volume":"17","author":"Deng","year":"2009","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"2","key":"10.1016\/j.nano.2021.102469_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004456","article-title":"Delayed time-to-treatment of an antisense morpholino oligomer is effective against lethal Marburg virus infection in Cynomolgus macaques","volume":"10","author":"Warren","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"33","key":"10.1016\/j.nano.2021.102469_bb0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mib.2016.05.017","article-title":"Antisense antimicrobial therapeutics","volume":"3","author":"Sully","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.nano.2021.102469_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.med.55.091902.104408","article-title":"Progress in antisense technology","volume":"55","author":"Crooke","year":"2004","journal-title":"Annu Ver Med"},{"issue":"3","key":"10.1016\/j.nano.2021.102469_bb0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: a comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol"},{"issue":"5","key":"10.1016\/j.nano.2021.102469_bb0260","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","article-title":"Nonfilamentous C. albicans mutants are avirulent","volume":"90","author":"Lo","year":"1997","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.nano.2021.102469_bb0265","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/sj.jid.5700346","article-title":"Hyphal invasion of Candida albicans inhibits the expression of human \u03b2-defensins in experimental oral candidiasis","volume":"126","author":"Lu","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.nano.2021.102469_bb0270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jinf.2014.06.002","article-title":"Candida albicans promotes invasion and colonisation of Candida glabrata in a reconstituted human vaginal epithelium","volume":"69","author":"Alves","year":"2014","journal-title":"J Infect"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342100112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342100112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:32:39Z","timestamp":1778617959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996342100112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["S154996342100112X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102469","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense locked nucleic acid gapmers to control Candida albicans filamentation","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102469"}}